As per Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Torrent Pharmaceuticals has informed that the Company has received the information regarding loss of share certificate as per details enclosed. The duplicate shares shall be issued on receipt of all the required documents from the shareholder. Further, they are enclosing the letter received from RTA Kfin Technologies in the said matter as a proof of the date of receipt of information by the Company.
The above information is a part of company’s filings submitted to BSE.
